Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice
Landis R. Walsh, Chaofan Yuan, James T. Boothe, Heather Conway, Andres E. Mindiola Romero, Odeth Barrett-Campbell, Swaroopa Yerrabothala, Frederick Lansigan
Abstract
We present the case of a 55-year-old woman who presented with laboratory studies concerning for acute myeloid leukemia (AML) as well as obstructive cholestasis. In similar previously reported cases, concerns of chemotherapy toxicity exacerbated by liver dysfunction or concerns of untreated, concurrent cholecystitis in a neutropenic patient often delay initiation of chemotherapy for full medical workup. At admission, our patient was started on the cytoreductive agent hydroxyurea. By day 10 of her medical workup, her liver function had improved with total bilirubin levels normalizing. At that time, full-dose 7 + 3 induction with cytarabine and daunorubicin was then initiated.